
Benazepril HCl
CAS number: 86541-74-4
Molecular formula: C24H29ClN2O5
molecular weight: 460.95
Chemical structure:
Producers shown on SFDA
(Record date:02/09/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Wisdom Pharmaceutical Co., Ltd. | GMP | Valid till February 2023 |
Huizhou Salubris pharmaceuticals Co, Ltd. | GMP | Valid till May 2021 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | GMP, DMF | Valid till September 2019 |
Shenzhen Salubris Pharmaceuticals Co., Ltd. | GMP | Valid till June 2019 |
Fujian Huitian Bio-pharma Co., Ltd. | GMP | Valid till October 2024 |
Producers shown on EP
Not showing any
Producer:Wisdom Pharmaceutical Co., Ltd., founded in 2000 and located in Nantong City, Jiangsu Province, is a pharmaceutical enterprise mainly engaged in high threshold and high value-added characteristic API, and provides new drug cdmo one-stop service for excellent preparation companies at home and abroad.
The company has successively passed the international official certification of the State Food and Drug Administration (nmpa), the Ministry of agriculture of China (MOA), the U.S. Food and Drug Administration (USFDA), the European Union food and Drug Administration (EDQM), the Japan food and Drug Administration (PMDA), the Ministry of food and drug safety of South Korea (MFDs) and so on.
The company has a sound process development and quality R & D system, and is equipped with dozens of international advanced analysis and testing facilities (currently 251 sets). It has successively passed iso140001 environmental management system, OHSAS18001 occupational health management system certification, ecovadis certification, and PSCI audit of many well-known international pharmaceutical enterprises.
Registered capital:RMB 99.72663819 million
Producer:Huizhou Salubris pharmaceuticals Co, Ltd. is a subsidiary of Shenzhen salubris Pharmaceuticals Co., Ltd.It is a high-end biopharmaceutical manufacturer integrating R & D, production and sales. It is committed to the research, development and production of cardiovascular, anti diabetic, anti-tumor, anti infective materials, and product groups around cardiovascular and cerebrovascular diseases.
Staff size:100-199 persons
Registered capital:RMB 45 million
Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.
Staff size:About 7000 persons
Registered capital:RMB 1 billion 492 million
Producer:Shenzhen Salubris Pharmaceuticals Co., Ltd., established in 1998 and listed on Shenzhen Stock Exchange in 2009, is a comprehensive pharmaceutical listed company integrating pharmaceutical product R & D, production and sales. The company accurately distributes the global industrial chain, covering more than 30 countries and regions such as China, the United States, Germany, France and Japan. All products and production workshops of the company have passed the domestic GMP certification, Daya Bay production base has passed the EU GMP certification, and the key product Taijia has obtained the listing license of 12 EU countries. All kinds of products enjoy a good reputation in the industry.
Staff size:About 3500 persons
Registered capital:RMB 1 billion 115 million
Producer:Fujian Huitian Bio-pharma Co., Ltd. ( formerly Fujian Sanming Pharmaceutical Company).
The company has fully passed the national GMP authentication. The production base covers an area of 108000 square meters and a construction area of 87400 square meters. At present, there are 9 workshops and a provincial technical center, with multiple production lines such as antibiotic API, powder injection, tablet, water injection, capsule, multi-functional traditional Chinese medicine extraction and biochemical extraction and refining.
Registered capital:RMB 200 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978